Bansback N - Search Results

1

Using a discrete choice experiment to estimate health state utility values.

Bansback N, Brazier J, Tsuchiya A, Anis A. Bansback N, et al. J Health Econ. 2012 Jan;31(1):306-18. doi: 10.1016/j.jhealeco.2011.11.004. Epub 2011 Dec 6. J Health Econ. 2012. PMID: 22197308

2

Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK. How important is quality of life?

Bansback N, Ward S, Karnon J. Bansback N, et al. Eur J Health Econ. 2004 Jun;5(2):188-9. doi: 10.1007/s10198-004-0226-5. Eur J Health Econ. 2004. PMID: 15452756 No abstract available.

3

The impact of age-related macular degeneration on health status utility values.

Espallargues M, Czoski-Murray CJ, Bansback NJ, Carlton J, Lewis GM, Hughes LA, Brand CS, Brazier JE. Espallargues M, et al. Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4016-23. doi: 10.1167/iovs.05-0072. Invest Ophthalmol Vis Sci. 2005. PMID: 16249475

4

Using contrast sensitivity to estimate the cost-effectiveness of verteporfin in patients with predominantly classic age-related macular degeneration.

Bansback N, Davis S, Brazier J. Bansback N, et al. Eye (Lond). 2007 Dec;21(12):1455-63. doi: 10.1038/sj.eye.6702636. Epub 2006 Nov 10. Eye (Lond). 2007. PMID: 17086167

5

Determinants of health related quality of life and health state utility in patients with age related macular degeneration: the association of contrast sensitivity and visual acuity.

Bansback N, Czoski-Murray C, Carlton J, Lewis G, Hughes L, Espallargues M, Brand C, Brazier J. Bansback N, et al. Qual Life Res. 2007 Apr;16(3):533-43. doi: 10.1007/s11136-006-9126-8. Epub 2006 Nov 22. Qual Life Res. 2007. PMID: 17119846

6

Considerations and preliminary proposals for defining a reference case for economic evaluations in ankylosing spondylitis.

Bansback N, Maetzel A, Drummond M, Anis A, Marra C, Conway P, Boers M, Tugwell P, Boonen A. Bansback N, et al. J Rheumatol. 2007 May;34(5):1178-83. J Rheumatol. 2007. PMID: 17477483

7

Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis.

Bansback N, Marra C, Tsuchiya A, Anis A, Guh D, Hammond T, Brazier J. Bansback N, et al. Arthritis Rheum. 2007 Aug 15;57(6):963-71. doi: 10.1002/art.22885. Arthritis Rheum. 2007. PMID: 17665482 Free article.

8

Impact of the recall period on measuring health utilities for acute events.

Bansback N, Sun H, Guh DP, Li X, Nosyk B, Griffin S, Barnett PG, Anis AH; OPTIMA TEAM. Bansback N, et al. Health Econ. 2008 Dec;17(12):1413-9. doi: 10.1002/hec.1351. Health Econ. 2008. PMID: 18404664 Clinical Trial.

9

Economic evaluations in rheumatoid arthritis: a critical review of measures used to define health States.

Bansback N, Ara R, Karnon J, Anis A. Bansback N, et al. Pharmacoeconomics. 2008;26(5):395-408. doi: 10.2165/00019053-200826050-00004. Pharmacoeconomics. 2008. PMID: 18429656 Review.

10

Health state utility values: a description of their development and application for rheumatic diseases.

Bansback N, Harrison M, Brazier J, Davies L, Kopec J, Marra C, Symmons D, Anis A. Bansback N, et al. Arthritis Rheum. 2008 Jul 15;59(7):1018-26. doi: 10.1002/art.23813. Arthritis Rheum. 2008. PMID: 18576311 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters